Coca-Cola is considering developing a line of cannabis-infused beverages, according to reports.
Sources told the Canadian business website that the product would be marketed as a recovery drink, designed to ease pain and inflammation, rather than one intended to get users high.
Article continues belowThe Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Canada is set to become the first G7 nation to legalise recreational marijuana use next month, after years of permitting it for medicinal purposes.
The soft drink giant’s “possible foray into the marijuana sector comes as beverage makers are trying to add cannabis as a trendy ingredient while their traditional businesses slow,” says Bloomberg.
Last month, Corona beer brewer Constellation Brands Inc. announced a $3.8bn increase in its stake in Canadian marijuana producer Canopy Growth Corp. It follows beer giant Molson Coors Brewing’s decision to make cannabis-infused drinks with Hydrotherapy.
But a partnership between Coke and Aurora “would mark the first entry of a major manufacturer of non-alcoholic drinks into the market,” the BBC reports.
Responding to the report, a Coca-Cola spokesperson said the company is “closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world,” but added that “no decisions have been made” yet.